Alle News

Icon, Computational Health, Featured Publication

Featured Publication, Computational Health, ITG,

Understanding Multimorbidity: The Link between Type 2 Diabetes and Osteoarthritis

The coexistence of multiple chronic diseases in a single individual, defined as multimorbidity, poses a significant challenge in healthcare as the global population ages. In a collaborative effort, researchers investigated the link between type 2…

Big genomic data visualization

Computational Health, ITG,

Big Data at Your Bedside

Analysis of genes can help in detecting diseases at an early stage as well as in determining new drug targets for therapy. Thanks to extremely powerful data processing, the field holds great promise for advancement. Helmholtz Munich is particularly…

HMGU_AI_Keyvisual_quer_ohneText

Awards & Grants, Computational Health, ICB, ITG, AIH, Pioneer Campus,

Successful evaluation of Helmholtz AI

Helmholtz AI is a research-driven hub for applied artificial intelligence (AI) and one of five platforms initiated by the Helmholtz Information and Data Science Incubator. Three years after the foundation, Helmholtz AI underwent a review in October…

Sarah Kim-Hellmuth

Awards & Grants, Computational Health, ITG,

Sarah Kim-Hellmuth Receives Friedmund Neumann Prize 2022

Dr. Sarah Kim-Hellmuth, Research Group Leader at the Helmholtz Munich Institute of Translational Genomics will be awarded the Friedmund Neumann Prize 2022 for her groundbreaking work in studying the genetic influence on human gene activity.

The Genetic Burden of Osteoarthritis - Cindy G. Boer

New Research Findings, Computational Health, ITG,

Milestone in Osteoarthritis Research

Researchers found new genetic risk factors for osteoarthritis and identified novel drug targets. Their finding is a milestone towards the development of the first ever curative treatment for osteoarthritis. The study involved an international…

Eleftheria Zeggini

Awards & Grants, Computational Health, ITG,

Eleftheria Zeggini Awarded EMBO Membership

Eleftheria Zeggini, founding director of the Institute of Translational Genomics at Helmholtz Zentrum München, has been elected a member of the European Molecular Biology Organization (EMBO). Today, EMBO announced the names of the international…